ArticleBlood research2026

Clonal hematopoietic mutations as a predictor of adverse outcomes in cytopenic patients with chronic kidney disease.

Suwannaporn Yaophrukchai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.